journal article·2018-10-31

Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy

Shunxiu Cao, Jiamin Guo, Yujing He, Murad Alahdal, Shanshan Tang, Yuekui Zhao, Zhaocong Yang, Huashan Gao, Wenjun Hu, Hulin Jiang, Lianju Qin, Liang Jin

Publisher page

Abstract

The main challenge of anticancer drugs is poor tumor targeting. Now cellular carriers are widely investigated to deliver anticancer agents. As an ideal cellular candidate, human umbilical cord derived mesenchymal stem cells (hUC-MSCs) possess inherent tropism potential to tumor. Here, we constructed hUC-MSCs carrying transferrin-inspired-nanoparticles that contain doxorubicin(hUC-MSCs-Tf-inspired-NPs) to achieve enhanced anti-tumor efficacy and made an evaluation. Results represented that hUC-MSCs-Tf-inspired-NPs not only exhibit the controlled-release property of Tf-inspired-NPs, but also integrate tumor tropism and penetrative abilities of MSCs. The tumor volume of nude mice bearing breast cancer MCF-7 treated with hUC-MSCs-Tf-inspired-NPs, was remarkably reduced compared to those treated with free drug or Tf-inspired-NPs. Thus, Tf-inspired-NPs loaded hUC-MSCs have a potential to deliver anticancer drugs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Mesenchymal stem cell research · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Life Science and Technology, China Pharmaceutical University

Department of Pharmaceutics, China Pharmaceutical University

First Affiliated Hospital, Nanjing Medical University

Funding

This study was funded by National Natural Science Foundation of China · National High Technology Research and Development Program of China · Top-notch Academic Programs Project of Jiangsu Higher Education Institutions · The science and technology innovation team of “Jiangsu Province Blue Project” · Jiangsu province science and technology innovation team · Excellent Youth Foundation of Jiangsu Scientific Committee and Priority Academic Program Development of Jiangsu Higher Education Institutions

References (40)

Show source-provided references
1. 10.3322/caac.2010710.3322/caac.20107 ↗
2. 10.1126/science.109583310.1126/science.1095833 ↗
3. 10.1007/s11095-006-9132-010.1007/s11095-006-9132-0 ↗
4. 10.1016/j.bcp.2010.04.02010.1016/j.bcp.2010.04.020 ↗
5. 10.3109/10731199.2012.69606710.3109/10731199.2012.696067 ↗
6. 10.1016/j.biomaterials.2016.11.00110.1016/j.biomaterials.2016.11.001 ↗
7. 10.1016/j.addr.2010.08.01010.1016/j.addr.2010.08.010 ↗
8. 10.1016/j.addr.2011.06.01010.1016/j.addr.2011.06.010 ↗
9. 10.1038/sj.gt.330227610.1038/sj.gt.3302276 ↗
10. 10.1016/j.canlet.2009.08.03110.1016/j.canlet.2009.08.031 ↗
11. 10.1007/s12307-010-0041-810.1007/s12307-010-0041-8 ↗
12. 10.1126/scitranslmed.300536510.1126/scitranslmed.3005365 ↗
13. 10.1016/S0024-3205(99)00272-610.1016/S0024-3205(99)00272-6 ↗
14. 10.1038/srep4475810.1038/srep44758 ↗
15. 10.1371/journal.pone.002832110.1371/journal.pone.0028321 ↗
16. 10.1073/pnas.080664710610.1073/pnas.0806647106 ↗
17. 10.1166/jnn.2012.619810.1166/jnn.2012.6198 ↗
18. 10.1021/nl052396o10.1021/nl052396o ↗
19. 10.1126/science.284.5411.14310.1126/science.284.5411.143 ↗
20. 10.1080/1465324060085590510.1080/14653240600855905 ↗
21. 10.1038/nnano.2017.5410.1038/nnano.2017.54 ↗
22. 10.3109/21691401.2015.102963310.3109/21691401.2015.1029633 ↗
23. 10.1016/j.addr.2004.02.01410.1016/j.addr.2004.02.014 ↗
24. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
25. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nature reviews. J Clin Oncol. 2010;7:653–664.
26. 10.3109/21691401.2014.97180710.3109/21691401.2014.971807 ↗
27. 10.1016/j.addr.2010.03.01110.1016/j.addr.2010.03.011 ↗
28. 10.1021/mp500565q10.1021/mp500565q ↗
29. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nature reviews. Cancer. 2006;6:583–592.
30. 10.1021/nn102055s10.1021/nn102055s ↗
31. 10.1016/j.nano.2012.06.00310.1016/j.nano.2012.06.003 ↗
32. 10.1016/j.ymeth.2015.03.00210.1016/j.ymeth.2015.03.002 ↗
33. 10.2174/157489281166615111114272110.2174/1574892811666151111142721 ↗
34. Armulik A. Splice variants of human beta 1 integrins: origin, biosynthesis and functions. Front Biosci. 2002;7:d219–d227.
35. Ebrahim EK, Assem MM, Amin AI, et al. FLT3 internal tandem duplication mutation, cMPL and CD34 expressions predict low survival in acute myeloid leukemia patients. Ann Clin Lab Sci. 2016;46:592–600.
36. 10.1016/0378-1119(95)00574-910.1016/0378-1119(95)00574-9 ↗
37. 10.1111/febs.1412610.1111/febs.14126 ↗
38. 10.1038/8265910.1038/82659 ↗
39. Leyton L, Hagood JS. Thy-1 modulates neurological cell-cell and cell-matrix interactions through multiple molecular interactions. Adv Neurol. 2014;8:3–20.
40. 10.1111/sji.1247710.1111/sji.12477 ↗